| Heading: |
Respiratory Syncytial Virus: Vaccination |
| Question ID: |
1820482 |
| UIN: |
65656 |
| House: |
Commons |
| Date tabled: |
2025-07-07 |
| Asking Member ID: |
5068 |
| Asking Member display name: |
Shivani Raja
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Shivani Raja
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, what his planned timeline is for the publication of an assessment of the (a) efficacy and (b) impact of the maternal vaccination programme for respiratory syncytial virus. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-07-11 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4981 |
| Answering Member display name: |
Ashley Dalton
|
| Answering Member handle: |
AshleyDalton_MP
|
| Answering Member Twitter reference: |
@AshleyDalton_MP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The UK Health Security Agency undertakes monitoring and evaluation of immunisation programmes, including the effectiveness of vaccines. Monitoring and evaluation work has begun for the new respiratory syncytial virus programmes which launched in September... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |